These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 25496852)
21. Hsa-miR-31-3p expression is linked to progression-free survival in patients with KRAS wild-type metastatic colorectal cancer treated with anti-EGFR therapy. Manceau G; Imbeaud S; Thiébaut R; Liébaert F; Fontaine K; Rousseau F; Génin B; Le Corre D; Didelot A; Vincent M; Bachet JB; Chibaudel B; Bouché O; Landi B; Bibeau F; Leroy K; Penault-Llorca F; Van Laethem JL; Demetter P; Tejpar S; Rossi S; Mosakhani N; Osterlund P; Ristamäki R; Sarhadi V; Knuutila S; Boige V; André T; Laurent-Puig P Clin Cancer Res; 2014 Jun; 20(12):3338-47. PubMed ID: 24771647 [TBL] [Abstract][Full Text] [Related]
22. Comparison of Circulating miRNAs Expression Alterations in Matched Tissue and Plasma Samples During Colorectal Cancer Progression. Nagy ZB; Barták BK; Kalmár A; Galamb O; Wichmann B; Dank M; Igaz P; Tulassay Z; Molnár B Pathol Oncol Res; 2019 Jan; 25(1):97-105. PubMed ID: 28980150 [TBL] [Abstract][Full Text] [Related]
23. MicroRNA Expression Levels and Histopathological Features of Colorectal Cancer. Emami SS; Akbari A; Zare AA; Agah S; Masoodi M; Talebi A; Minaeian S; Fattahi A; Moghadamnia F J Gastrointest Cancer; 2019 Jun; 50(2):276-284. PubMed ID: 29404790 [TBL] [Abstract][Full Text] [Related]
24. MicroRNA and targeted mRNA expression profiling analysis in human colorectal adenomas and adenocarcinomas. Gattolliat CH; Uguen A; Pesson M; Trillet K; Simon B; Doucet L; Robaszkiewicz M; Corcos L Eur J Cancer; 2015 Feb; 51(3):409-20. PubMed ID: 25586944 [TBL] [Abstract][Full Text] [Related]
25. KRAS mutations in traditional serrated adenomas from Korea herald an aggressive phenotype. Kim KM; Lee EJ; Kim YH; Chang DK; Odze RD Am J Surg Pathol; 2010 May; 34(5):667-75. PubMed ID: 20305537 [TBL] [Abstract][Full Text] [Related]
26. Circulating miRNAs miR-34a and miR-150 associated with colorectal cancer progression. Aherne ST; Madden SF; Hughes DJ; Pardini B; Naccarati A; Levy M; Vodicka P; Neary P; Dowling P; Clynes M BMC Cancer; 2015 Apr; 15():329. PubMed ID: 25924769 [TBL] [Abstract][Full Text] [Related]
27. microRNA-17 Is the Most Up-Regulated Member of the miR-17-92 Cluster during Early Colon Cancer Evolution. Knudsen KN; Nielsen BS; Lindebjerg J; Hansen TF; Holst R; Sørensen FB PLoS One; 2015; 10(10):e0140503. PubMed ID: 26465597 [TBL] [Abstract][Full Text] [Related]
28. Expression and clinical significance of miRNA-34a in colorectal cancer. Ma ZB; Kong XL; Cui G; Ren CC; Zhang YJ; Fan SJ; Li YH Asian Pac J Cancer Prev; 2014; 15(21):9265-70. PubMed ID: 25422210 [TBL] [Abstract][Full Text] [Related]
29. Differential expression of microRNA 181b and microRNA 21 in hyperplastic polyps and sessile serrated adenomas of the colon. Schmitz KJ; Hey S; Schinwald A; Wohlschlaeger J; Baba HA; Worm K; Schmid KW Virchows Arch; 2009 Jul; 455(1):49-54. PubMed ID: 19547998 [TBL] [Abstract][Full Text] [Related]
31. Identification of LncPVT1 and CircPVT1 as prognostic biomarkers in human colorectal polyps. RezaSoltani M; Forouzesh F; Salehi Z; Zabihi MR; Rejali L; Nazemalhosseini-Mojarad E Sci Rep; 2023 Aug; 13(1):13113. PubMed ID: 37573419 [TBL] [Abstract][Full Text] [Related]
32. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression. Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739 [TBL] [Abstract][Full Text] [Related]
33. Contribution of microRNA-149, microRNA-146a, and microRNA-196a2 SNPs in colorectal cancer risk and clinicopathological features in Tunisia. Chayeb V; Mahjoub S; Zitouni H; Jrah-Harzallah H; Zouari K; Letaief R; Mahjoub T Gene; 2018 Aug; 666():100-107. PubMed ID: 29715515 [TBL] [Abstract][Full Text] [Related]
34. Expression of cytokeratins 7 and 20 in serrated adenoma and related diseases. Tatsumi N; Mukaisho K; Mitsufuji S; Tatsumi Y; Sugihara H; Okanoue T; Hattori T Dig Dis Sci; 2005 Sep; 50(9):1741-6. PubMed ID: 16133982 [TBL] [Abstract][Full Text] [Related]
35. miR-135b Promotes Cancer Progression by Targeting Transforming Growth Factor Beta Receptor II (TGFBR2) in Colorectal Cancer. Li J; Liang H; Bai M; Ning T; Wang C; Fan Q; Wang Y; Fu Z; Wang N; Liu R; Zen K; Zhang CY; Chen X; Ba Y PLoS One; 2015; 10(6):e0130194. PubMed ID: 26061281 [TBL] [Abstract][Full Text] [Related]
36. Computational Analysis of miRNA and their Gene Targets Significantly Involved in Colorectal Cancer Progression. Kandhavelu J; Subramanian K; Khan A; Omar A; Ruff P; Penny C Microrna; 2019; 8(1):68-75. PubMed ID: 30073936 [TBL] [Abstract][Full Text] [Related]
37. Role of miRNA-210, miRNA-21 and miRNA-126 as diagnostic biomarkers in colorectal carcinoma: impact of HIF-1α-VEGF signaling pathway. Sabry D; El-Deek SEM; Maher M; El-Baz MAH; El-Bader HM; Amer E; Hassan EA; Fathy W; El-Deek HEM Mol Cell Biochem; 2019 Apr; 454(1-2):177-189. PubMed ID: 30357530 [TBL] [Abstract][Full Text] [Related]
38. Serrated polyps and colorectal cancer: new pathway to malignancy. Noffsinger AE Annu Rev Pathol; 2009; 4():343-64. PubMed ID: 19400693 [TBL] [Abstract][Full Text] [Related]
39. Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway. Liu B; Liu Y; Zhao L; Pan Y; Shan Y; Li Y; Jia L Mol Carcinog; 2017 Dec; 56(12):2669-2680. PubMed ID: 28767179 [TBL] [Abstract][Full Text] [Related]
40. MicroRNA hsa-miR-135b regulates mineralization in osteogenic differentiation of human unrestricted somatic stem cells. Schaap-Oziemlak AM; Raymakers RA; Bergevoet SM; Gilissen C; Jansen BJ; Adema GJ; Kögler G; le Sage C; Agami R; van der Reijden BA; Jansen JH Stem Cells Dev; 2010 Jun; 19(6):877-85. PubMed ID: 19795981 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]